Henggui Hu

Dr. Henggui Hu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 November 2024 in Food Science and Human Wellness
Verified
Journal Article
Open access
PDF file
HDHong Duan
Hong Duan
WWWei Wang
Wei Wang
SLShu Li
Shu Li
HLHan Li
Han Li
Ghulam Jilany KhanGhulam Jilany Khan
Ghulam Jilany Khan
Lili LiLili Li
Lili Li
Corona Virus Disease 2019 (COVID-19) has brought the new challenges to scientific research. Isodon suzhouensis has good anti-inflammatory and antioxidant stress effects, which is considered as a potential treatment for COVID-19. The possibility for the treatment of COVID-19 with suzhouensis and its potential mechanism of action were explored by employing molecular docking and network pharmacology. Network pharmacology and molecular docking were used to screen drug targets, and Lipopolysaccharide (LPS) induced RAW264.7 and NR8383 cells inflammation model was used for experimental verification. Collectively a total of 209 possible linkages against 18 chemical components from suzhouensis and 1194 COVID-19 related targets were selected. Among these, 164 common targets were obtained from the intersection of suzhouensis and COVID-19. GO and KEGG enriched 582 function targets and 87 target proteins pathways, respectively. The results from molecular docking studies revealed that rutin, vitexin, isoquercitrin and quercetin had significant binding ability with SARS-CoV-23CLpro and ACE2. In vitro studies showed that Isodon suzhouensis extract (ISE) may inhibit the activation of PI3K/Akt pathway and the expression level of downstream pro-inflammatory factors by inhibiting the activation of EGFR in RAW264.7 cells induced by LPS. In addition, ISE was able to inhibit the activation of TLR4/NF-κB signaling pathway in NR8383 cells exposed to LPS. Overall, the network pharmacology and in vitro studies conclude that active components from suzhouensis have strong therapeutic potential against COVID-19 through multi-target, multi-pathway dimensions and can be a promising candidate against COVID-19.

9 December 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SZSirong Zhang
Sirong Zhang
JLJie Li
Jie Li
MDMan Ding
Man Ding
GKGhulam Jilany Khan
Ghulam Jilany Khan
AAAdina Abuduaini
Adina Abuduaini
KZKefeng Zhai
Kefeng Zhai

23 June 2025 in Translational Oncology
Verified
Journal Article
Open access
HDHong Duan
Hong Duan
JJJianhu Jia
Jianhu Jia
TWTingting Wang
Tingting Wang
Ghulam Jilany KhanGhulam Jilany Khan
Ghulam Jilany Khan
LWLi Wang
Li Wang
KZKefeng Zhai
Kefeng Zhai
Colorectal cancer (CRC) is among top most common cancers with high mortality rate and major health issue yet to resolve across the globe. miR-23b is an oncogene in many cancers including CRC. The route of involvement of miR-23b in the regulation of CRC is still unclear. Study explored bioregulatory mechanism of miR-23b against CRC involving in vitro and animal model experimentation via experimentation involving ki67 immunohistochemistry, CCK8, EDU, and Transwell cell migration. The bioinformatic studies were employed to predict miR-23b target tumor suppressor PTPRG while the luciferase reporter gene assay was used to find the binding capabilities of miR-23b to the 3'-UTR of PTPRG. The changes in the expression of miR-23b were found in three CRC cell lines including SW480, HT29, and Caco2, and their correlation with PTPRG protein were assessed through western blot and RT-PCR. Moreover, the association of PTPRG gene in the SW480 cell on CRC by CCK8, EDU, and Transwell cell migration assay. Furthermore, we also detected the PTPRG protein levels in clinical samples of the tissues. Afterwards, the regulatory involvement PTPRG through miR-23b was studied by means of co-overexpression in both animals based and cell-based studies. CRC growth is associated with miR-23b and directly targets the PTPRG in CRC cells. PTPRG may restrict the cell proliferation and migration and can restore the miR-23b mediated CRC growth. MiR-23b is directly linked with the CRC development via PTPRG restriction suggesting miR-23b as novel therapeutic target against CRC.

1 May 2026 in Food Science and Human Wellness
Verified
Journal Article
Open access
PDF file
JZJing Zhou
Jing Zhou
YSYing Shi
Ying Shi
ZBZuzhen Bao
Zuzhen Bao
MLMengmeng Luo
Mengmeng Luo
JLJie Li
Jie Li
KZKefeng Zhai
Kefeng Zhai
Background: Metabolic associated fatty liver disease (MAFLD) is closeky linked to metabolic disorders and lack of effective therapeutic options. Schisandrin A (SA), derived from the traditional Chinese medicinal herb Schisandra, has shown liver-protective properties. SA may counteract MAFLD by modulating endoplasmic reticulum stress (ERS) and inhibiting apoptosis. This study aimed to investigate the protective effects of SA on high-fat diet-induced MAFLD in C57BL/6 mice. The study also sought to elucidate the underlying mechanisms, focusing on the ERS signaling pathway and apoptosis. Methods: MAFLD mice models were induced with a high-fat diet and divided into control, model, SA intervention (various dosages), atorvastatin positive control, and ERS inhibitor combined with SA intervention groups. serum lipid profiles, liver enzymes, and liver histopathology were assessed. Western blot, immunofluorescence, and TUNEL assay were used to evaluate ERS and apoptosis-related protein expression. Results: SA intervention markedly enhanced serum lipid profiles and reduced liver enzyme levels. The histopathological alterations observed in the model group were significantly mitigated by SA treatment. Western blot analysis revealed that SA effectively modulated the expression levels of proteins associated with ERS and apoptosis. Furthermore, immunofluorescence and TUNEL assay results substantiated SA's regulatory influence on ERS and apoptotic pathways. Conclusion: SA effectively improved dyslipidemia and hepatic lipid metabolism abnormalities. It reduced hepatic lipid deposition and pathological damage in MAFLD mice induced by a high-fat diet. The mechanism of action may involve the regulation of the ERS signaling pathway, thereby protecting cells from apoptosis.